We found altered serum levels of astrocyte-related biomarkers in CID patients, with increases in S100B and glial fibrillary acidic protein and decreases in BDNF and GDNF, which led us to hypothesize a role of astrocyte dysfunction in CID (14). This evidence concerns the gene GFAP and combined immunodeficiency.